Tandia, Mahamadou <br/><br/>
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  04 2017 
 - 759-766 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-017-3268-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>ATP Binding Cassette Transporter, Subfamily G, Member 2--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--pharmacokinetics<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Hepatocellular--drug therapy<br/>DNA--genetics<br/>Drug Monitoring<br/>Female<br/>Genotype<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--pharmacokinetics<br/>Polymorphism, Genetic--genetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Protein Kinase Inhibitors--pharmacokinetics<br/>Sorafenib<br/>Treatment Outcome